Cardinal Health (CAH) Cash from Investing Activities (2009 - 2026)
Cardinal Health's (CAH) quarterly Cash from Investing Activities came in at -$181.0 million in Q1 2026, up 93.75% year-on-year from -$93.4 million in Q1 2025, and up 90.86% quarter-over-quarter from -$2.0 billion in Q4 2025.
Cardinal Health (CAH) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Cardinal Health has disclosed Cash from Investing Activities across 18 years of filings, most recently posting -$181.0 million for Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$181.0 million, up 93.75% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.9 billion (down 3.64% YoY), and the FY2025 annual result was -$5.6 billion, down 202.49% from the prior year.
- Cash from Investing Activities came in at -$181.0 million for Q1 2026 at Cardinal Health, up from -$2.0 billion in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $166.0 million in Q2 2024 to a low of -$2.9 billion in Q1 2025.
- The 5-year median for Cash from Investing Activities is -$142.0 million (2025), against an average of -$614.5 million.
- Peak annual rise in Cash from Investing Activities reached 180.58% in 2024, while the deepest fall reached 1929.67% in 2024.
- Cardinal Health's Cash from Investing Activities stood at -$87.0 million in 2022, then slipped by 20.69% to -$105.0 million in 2023, then slumped by 829.52% to -$976.0 million in 2024, then plunged by 102.87% to -$2.0 billion in 2025, then jumped by 90.86% to -$181.0 million in 2026.
- The last three Cash from Investing Activities figures came in at -$181.0 million (Q1 2026), -$2.0 billion (Q4 2025), and -$142.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 425.00 Mn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | -4.87 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -181.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -63.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 53.93 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -754,000.00 |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -3.21 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -708,963.00 |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -181.00 Mn |
| Mar 31, 2026 | -181.00 Mn |
| Dec 31, 2025 | -1.98 Bn |
| Dec 31, 2025 | -1.98 Bn |
| Sep 30, 2025 | -142.00 Mn |
| Sep 30, 2025 | -142.00 Mn |
| Jun 30, 2025 | -1.63 Bn |
| Jun 30, 2025 | -1.63 Bn |
| Mar 31, 2025 | -2.90 Bn |
| Mar 31, 2025 | -2.90 Bn |
| Dec 31, 2024 | -976.00 Mn |
| Dec 31, 2024 | -976.00 Mn |
| Sep 30, 2024 | -88.00 Mn |
| Sep 30, 2024 | -88.00 Mn |
| Jun 30, 2024 | 166.00 Mn |
| Jun 30, 2024 | 166.00 Mn |
| Mar 31, 2024 | -1.85 Bn |
| Mar 31, 2024 | -1.85 Bn |
| Dec 31, 2023 | -105.00 Mn |
| Dec 31, 2023 | -105.00 Mn |